Related references
Note: Only part of the references are listed.Experimental and computational correlation and prediction on herbicide resistance for acetohydroxyacid synthase mutants to Bispyribac
He YinWu et al.
SCIENCE CHINA-CHEMISTRY (2013)
Rational Approaches to Improving Selectivity in Drug Design
David J. Huggins et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Preliminary X-ray crystallographic studies of the catalytic subunit of Escherichia coli AHAS II with its cofactors
Xuhui Niu et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2011)
Which Compound to Select in Lead Optimization? Prospectively Validated Proteochemometric Models Guide Preclinical Development
Gerard J. P. van Westen et al.
PLOS ONE (2011)
Syntheses and herbicidal activity of new triazolopyrimidine-2-sulfonamides as acetohydroxyacid synthase inhibitor
Chao-Nan Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
3D-QSAR in Drug Design - A Review
Jitender Verma et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
The GRID/CPCA approach in drug discovery
Josmar R. Rocha et al.
EXPERT OPINION ON DRUG DISCOVERY (2010)
AHAS herbicide resistance endowing mutations: effect on AHAS functionality and plant growth
Qin Yu et al.
JOURNAL OF EXPERIMENTAL BOTANY (2010)
Computational Mutation Scanning and Drug Resistance Mechanisms of HIV-1 Protease Inhibitors
Ge-Fei Hao et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2010)
Detecting and understanding combinatorial mutation patterns responsible for HIV drug resistance
Jing Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Quantitative Prediction of Fold Resistance for Inhibitors of EGFR
Trent E. Balius et al.
BIOCHEMISTRY (2009)
Design and synthesis of N-2,6-difluorophenyl-5-methoxyl-1,2,4-triazolo[1,5-a]-pyrimidine-2-sulfonamide as acetohydroxyacid synthase inhibitor
Chao-Nan Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Prospective Ligand- and Target-Based 3D QSAR: State of the Art 2008
Robert D. Clark
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Proteochemometric Modeling of Drug Resistance over the Mutational Space for Multiple HIV Protease Variants and Multiple Protease Inhibitors
Maris Lapins et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Factors underlying sensitivity of cancers to small-molecule kinase inhibitors
Pasi A. Jaenne et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Homologous and heterologous interactions between catalytic and regulatory subunits of Escherichia coli acetohydroxyacid synthase I and III
Niu CongWei et al.
SCIENCE IN CHINA SERIES B-CHEMISTRY (2009)
Predicting drug-resistant mutations of HIV protease
Hiroshi Ishikita et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
Computational design and discovery of conformationally flexible inhibitors of acetohydroxyacid synthase to overcome drug resistance associated with the W586L mutation
Feng-Qin Ji et al.
CHEMMEDCHEM (2008)
Recent advances in QSAR and their applications in predicting the activities of chemical molecules, peptides and proteins for drug design
Qi-Shi Du et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2008)
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman et al.
NATURE BIOTECHNOLOGY (2008)
Structure and mechanism of inhibition of plant acetohydroxyacid synthase
Ronald G. Duggleby et al.
PLANT PHYSIOLOGY AND BIOCHEMISTRY (2008)
HIV drug development: the next 25 years
Charles Flexner
NATURE REVIEWS DRUG DISCOVERY (2007)
Rational design based on bioactive conformation analysis of pyrimidinylbenzoates as acetohydroxyacid synthase inhibitors by integrating molecular docking, CoMFA, CoMSIA, and DFT calculations
Yan-Zhen He et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
Study on structure-activity relationship of mutation-dependent herbicide resistance acetohydroxyacid synthase through 3D-QSAR and mutation
ZhiHong Yu et al.
CHINESE SCIENCE BULLETIN (2007)
Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: Mechanism for binding and drug resistance
Tingjun Hou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
3D QSAR selectivity analyses of carbonic anhydrase inhibitors:: Insights for the design of isozyme selective inhibitors
Alexander Weber et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
Genotypic predictors of human immunodeficiency virus type 1 drug resistance
Soo-Yon Rhee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Comparative binding energy analysis considering multiple receptors: A step toward 3D-QSAR models for multiple targets
Marta Murcia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Development of a general quantum-chemical descriptor for steric effects: Density functional theory based QSAR study of herbicidal sulfonylurea analogues
Zhen Xi et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2006)
Acetohydroxyacid synthase and its role in the biosynthetic pathway for branched-chain amino acids
J. A. McCourt et al.
AMINO ACIDS (2006)
Bioinformatics approach to predicting HIV drug resistance
F Cordes et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2006)
Development of quantitative structure-activity relationships and its application in rational drug design
Guang-Fu Yang et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Computational approaches to model ligand selectivity in drug design
AR Ortiz et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
AFMoC enhances predictivity of 3D QSAR: A case study with DOXP-reductoisomerase
K Silber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Computer prediction of drug resistance mutations in proteins
ZW Cao et al.
DRUG DISCOVERY TODAY (2005)
Interaction profiles of protein kinase-inhibitor complexes and their application to virtual screening
C Chuaqui et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Virtual screening with flexible docking and COMBINE-based models. Application to a series of factor Xa inhibitors
M Murcia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Structural interaction fingerprint (SIFt): A novel method for analyzing three-dimensional protein-ligand binding interactions
Z Deng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Evolutionary analysis of HIV-1 protease inhibitors: Methods for design of inhibitors that evade resistance
D Stoffler et al.
PROTEINS-STRUCTURE FUNCTION AND GENETICS (2002)
Diversity and complexity of HIV-1 drug resistance: A bioinformatics approach to predicting phenotype from genotype
N Beerenwinkel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Structural classification of protein kinases using 3D molecular interaction field analysis of their ligand binding sites: Target family landscapes
T Naumann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Comparative binding energy (COMBINE) analysis of influenza neuraminidase-inhibitor complexes
T Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Can an optimization/scoring procedure in ligand-protein docking be employed to probe drug-resistant mutations in proteins?
YZ Chen et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2001)
Altered target sites as a mechanism of herbicide resistance
MD Devine et al.
CROP PROTECTION (2000)
GRID/CPCA: A new computational tool to design selective ligands
MA Kastenholz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors
RE Wilcox et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
